Literature DB >> 19115177

Autonomic complications following central nervous system injury.

Ian J Baguley1.   

Abstract

Severe sympathetic overactivity occurs in several conditions that are recognized as medical emergencies. Following central nervous system injury, a small proportion of individuals develop severe paroxysmal sympathetic and motor overactivity. These individuals have a high attendant risk of unnecessary secondary morbidity. Following acquired brain injury, the syndrome is known by a number of names including dysautonomia and sympathetic storm. Dysautonomia is currently a diagnosis of exclusion and often goes unrecognized. The evidence base for management is almost entirely anecdotal in nature; there has been little structured or prospective research. In contrast, the evidence base for autonomic dysreflexia following spinal cord injury is much stronger, with level 1 evidence for many treatment interventions. This review presents a current understanding of each condition and suggests simple management protocols. With the marked disparity in the literature for the two conditions, the main focus is on the literature for dysautonomia. The similarity between these two conditions and the other autonomic emergency conditions is discussed.

Entities:  

Mesh:

Year:  2008        PMID: 19115177     DOI: 10.1055/s-0028-1105971

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Paroxysmal Sympathetic Hyperactivity in Critically Ill Children with Encephalitis and Meningoencephalitis.

Authors:  Raquel Farias-Moeller; Jessica L Carpenter; Nathan Dean; Elizabeth M Wells
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

2.  Neuroanatomical basis of paroxysmal sympathetic hyperactivity: a diffusion tensor imaging analysis.

Authors:  Holly E Hinson; Louis Puybasset; Nicolas Weiss; Vincent Perlbarg; Habib Benali; Damien Galanaud; Mike Lasarev; Robert D Stevens
Journal:  Brain Inj       Date:  2015-01-07       Impact factor: 2.311

3.  Early Fever As a Predictor of Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury.

Authors:  Holly E Hinson; Martin A Schreiber; Amber L Laurie; Ian J Baguley; Dennis Bourdette; Geoffrey S F Ling
Journal:  J Head Trauma Rehabil       Date:  2017 Sep/Oct       Impact factor: 2.710

Review 4.  Paroxysmal sympathetic hyperactivity after severe brain injury.

Authors:  Devon Lump; Megan Moyer
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

5.  Dysautonomia after pediatric brain injury.

Authors:  Katherine A Kirk; Michael Shoykhet; Jong H Jeong; Elizabeth C Tyler-Kabara; Maryanne J Henderson; Michael J Bell; Ericka L Fink
Journal:  Dev Med Child Neurol       Date:  2012-06-19       Impact factor: 5.449

Review 6.  Autonomic dysfunction syndromes after acute brain injury.

Authors:  Courtney Takahashi; Holly E Hinson; Ian J Baguley
Journal:  Handb Clin Neurol       Date:  2015

7.  Self-Awareness and Self-Ratings of On-Road Driving Performance After Traumatic Brain Injury.

Authors:  James R Gooden; Jennie L Ponsford; Judith L Charlton; Pamela E Ross; Shawn Marshall; Sylvain Gagnon; Michel Bédard; Renerus J Stolwyk
Journal:  J Head Trauma Rehabil       Date:  2017 Jan/Feb       Impact factor: 2.710

Review 8.  Paroxysmal sympathetic hyperactivity after acute brain injury.

Authors:  H Alex Choi; Sang-Beom Jeon; Sophie Samuel; Teresa Allison; Kiwon Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

9.  Bromocriptine for control of hyperthermia in a patient with mixed autonomic hyperactivity after neurosurgery: a case report.

Authors:  Seong Hee Kang; Min Ja Kim; Il Young Shin; Dae Won Park; Jang Wook Sohn; Young Kyung Yoon
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

Review 10.  Feeding Intolerance in Children with Severe Impairment of the Central Nervous System: Strategies for Treatment and Prevention.

Authors:  Julie Hauer
Journal:  Children (Basel)       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.